Precision Medicine market continues to demonstrate strong momentum within the healthcare and life sciences landscape. Valued at USD 130,400 million in 2024, the market is projected to reach USD 256,430 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.4% during the forecast period. This robust expansion highlights the growing shift toward individualized...

Autonomous Delivery Robots Are Rapidly Transforming Last Mile Logistics Into a Smarter Faster and More Resilient Ecosystem The race to redefine last-mile delivery is no longer just about speed it is about intelligence, adaptability, and long-term sustainability. Autonomous delivery robots are stepping into this space as a breakthrough solution, helping businesses navigate rising operational...

" According to the latest report published by Data Bridge Market Research, the Cancer Monoclonal Antibodies Market The global cancer monoclonal antibodies market size was valued at USD 53.33 billion in 2023 and is expected to reach USD 133.45 billion by 2031, at a CAGR of 14.00% during the forecast period. The world-class Cancer Monoclonal Antibodies Market report analyses some of the...

The global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....

The Global Deep Hyperthermia Devices Market continues to gain momentum as thermal oncology and precision-based cancer care advance across healthcare systems worldwide.  According to the latest analysis, the market was valued at USD 434 million in 2024 and is projected to reach USD 641 million by 2031, registering a 5.8% CAGR during the forecast period. The expanding demand for targeted,...

The anti-PD-1 antibody industry is experiencing significant momentum as immunotherapy continues to transform cancer treatment approaches worldwide. Growing investments in oncology research, expanding clinical applications, and increasing awareness of immune checkpoint inhibitors are creating new opportunities across healthcare systems. The Global Anti-PD-1 Antibody Market Future Trends reflect...

According to a newly published market research report by 24LifeSciences, the global BNCT boron drug market was valued at USD 72 million in 2024 and is projected to reach USD 160 million by 2031, growing at a compound annual growth rate (CAGR) of 12.3% during the forecast period. BNCT boron drugs comprise highly specialized pharmaceutical agents designed to selectively deliver boron-10 isotopes...

According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...

According to a newly published market research report by 24LifeSciences, Global Lenvatinib Mesylate Capsules Market was valued at USD 1.3 billion in 2024 and is projected to reach USD 2.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252032. Lenvatinib Mesylate, commercially known as Lenvima, is a multi-kinase inhibitor specifically...

The genome-based drug industry is transforming modern healthcare by enabling highly targeted therapies based on an individual's genetic profile. Advances in genomic science and molecular diagnostics are creating new possibilities for treating complex and inherited diseases. Growing adoption of precision medicine, increased investment in biotechnology research, and rapid developments in gene...